G. Aboagyemathiesen et al., PRODUCTION OF INTERFERONS IN HUMAN PLACENTAL TROPHOBLAST SUBPOPULATIONS AND THEIR POSSIBLE ROLES IN PREGNANCY, Clinical and diagnostic laboratory immunology, 1(6), 1994, pp. 650-659
The human cytotrophoblasts are the first fetal cells to arise during e
mbryogenesis and are the progenitor cells to villous (noninvasive), sy
ncytiotrophoblast (noninvasive), ''intermediate'' extravillous (invasi
ve), and ''anchoring'' extravillous (invasive) trophoblast subpopulati
ons. These trophoblast subpopulations were isolated from first- and th
ird-trimester placentae and were stimulated with Sendai virus, granulo
cyte-macrophage colony-stimulating factors (GM-CSF), and platelet-deri
ved growth factor (PDGF) to produce interferons (IFNs). GM-CSF and PDG
F induced very low levels of IFN in first-trimester extravillous troph
oblast cultures produced five- to eightfold more IFNs than villous tro
phoblast cultures and two- to fivefold more IFN than the syncytiotroph
oblast cultures when stimulated with Sendai virus. Syncytiotrophoblast
cultures produced higher levels of IFNs (up to twofold) than villous
trophoblast cultures when stimulated with the same virus. Pretreatment
of first-trimester extravillous and villous trophoblast cultures with
GM-CSF and PDGF followed by infection with Sendai virus resulted in g
reater IFN production than when the cultures were stimulated with viru
s alone. The levels of IFN produced were dependent on the type of trop
hoblast, the type of inducer, and the stage of differentiation of the
trophoblasts. The purified trophoblast IFNs have potent antiviral acti
vities when assayed on human amniotic WISH cells, and they inhibited p
roliferation of normal trophoblasts and trophoblast-derived malignant
cells in vitro without any toxicity. Furthermore, the trophoblast IFNs
activated NK cell activity and suppressed mitogen-stimulated lymphocy
te proliferation at concentrations of between 10 and 1,000 IU/ml. The
possible functions of the trophoblast IFNs during pregnancy are discus
sed with respect to human placental and fetal protection and developme
nt.